TE_64
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | LTR13 |
|---|---|
| TE superfamily | ERV2 |
| TE class | LTR |
| Gene | ACOT7 |
| Class | Chimeric |
| Coding | Non-coding, Other |
| Tumor-specific score | 3.19 |
| Counts of samples | TCGA_tumor:661; TCGA_normal:67; GTEx:166 |
| TSS | chr1(-):6363632 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_64.11 | ACOT7 | Chimeric | Non-coding | Non-coding | chr1(-):6281266,6281286,6294864,6294980,6318492,6318578,6327299,6327413,6333477,6333568,6339433,6339589,6349749,6349866,6356059,6356141,6362712,6363633 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
